GSI Technology, Inc. (GSIT) — Earnings Call X-Ray
Our AI read all 38 of GSIT's earnings calls (2016–2025) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.
Previous Call Grade
D
Q3 2025
Calls Analyzed
38
2016–2025
Avg Candor
6.5/9
evasion 2.8/9
Call-by-call analysis
🔒 Q4 2025 earnings call
2025-05-01
NEWEST
Guidance: ■■■■■Demand: ■■■■■■
Margins: ■■■■Backlog: ■■■■
■ analysts, ■■ questionsexpected move ±■■%
Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.
🔒 The Q4 2025 call grade is ready
The full 37-point AI read of GSIT's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock
D
Q3 2025 earnings call
2025-01-30
move ±25.7%
Management gave no formal guidance against steady demand and expanding margins. The delivery was rich in specifics.
Demand: stableMargins: expandingPricing: stableHeadcount: cutting 1 analysts · 2 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q2 2025 earnings call
2024-10-24
move ±14.5%
Management held guidance steady against accelerating demand and contracting margins. The delivery was rich in specifics, promotional in tone.
Guidance: maintainedDemand: acceleratingMargins: contractingHeadcount: cutting 1 analysts · 3 questions
⚑ Critic ammunition⚑ Question left hanging✓ Volume step-up ahead✓ Early product, fast growth⚑ Reads rehearsedFounder-led
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
YES Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q1 2025 earnings call
2024-07-25
move ±13.2%
Management gave no formal guidance against slowing demand and contracting margins. The delivery was unusually candid.
Demand: slowingMargins: contractingPricing: stableCapex: flat 4 analysts · 10 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q4 2024 earnings call
2024-05-03
move ±19.8%
Management lowered guidance against slowing demand and contracting margins.
Guidance: loweredDemand: slowingMargins: contractingHeadcount: flat
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
F
Q3 2024 earnings call
2024-01-25
move ±23.1%
Management held guidance steady against mixed demand signals. The delivery was rich in specifics, promotional in tone.
Guidance: maintainedDemand: mixedMargins: stablePricing: stableCapex: increasing 2 analysts · 6 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
F
Q2 2024 earnings call
2023-10-26
move ±30.8%
Management held guidance steady against slowing demand.
Guidance: maintainedDemand: slowingMargins: stablePricing: stableCapex: increasing 4 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hangingFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?
D
Q1 2024 earnings call
2023-07-27
move ±22.1%
Management gave no formal guidance against mixed demand signals and contracting margins. The delivery was rich in specifics.
Demand: mixedMargins: contractingBacklog: stablePricing: raisingHeadcount: growingCapex: flat 4 analysts · 14 questions
⚑ Critic ammunition⚑ Question left hanging⚑ Reads rehearsedFounder-ledDirection beats results
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
NO Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
YES Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
YES Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
Earlier calls
| Call | Date | Grade | Guidance | Demand | Margins | Candor | Evasion |
|---|
| Q4 2023 |
2023-05-16 |
D |
none | slowing | unclear |
7/9 |
3/9 |
| Q3 2023 |
2023-01-26 |
F |
lowered | slowing | contracting |
6/9 |
3/9 |
| Q2 2023 |
2022-10-29 |
F |
lowered | mixed | contracting |
6/9 |
4/9 |
| Q1 2023 |
2022-07-31 |
D |
maintained | stable | expanding |
6/9 |
3/9 |
| Q4 2022 |
2022-05-08 |
F |
none | stable | expanding |
6/9 |
4/9 |
| Q3 2022 |
2022-01-28 |
D |
maintained | stable | expanding |
7/9 |
2/9 |
| Q2 2022 |
2021-10-30 |
F |
maintained | mixed | stable |
6/9 |
4/9 |
| Q1 2022 |
2021-08-01 |
F |
lowered | stable | expanding |
6/9 |
2/9 |
| Q4 2021 |
2021-05-08 |
D |
raised | stable | expanding |
6/9 |
4/9 |
| Q3 2021 |
2021-01-28 |
F |
maintained | stable | stable |
6/9 |
3/9 |
| Q2 2021 |
2020-11-01 |
D |
none | mixed | stable |
7/9 |
2/9 |
| Q1 2021 |
2020-08-02 |
F |
lowered | slowing | contracting |
7/9 |
2/9 |
| Q1 2020 |
2020-05-09 |
F |
lowered | slowing | contracting |
6/9 |
3/9 |
| Q3 2020 |
2020-01-30 |
F |
lowered | mixed | contracting |
6/9 |
5/9 |
| Q2 2020 |
2019-10-24 |
F |
lowered | mixed | contracting |
6/9 |
5/9 |
| Q1 2019 |
2019-07-28 |
C |
maintained | stable | expanding |
7/9 |
2/9 |
| Q4 2019 |
2019-05-05 |
C |
maintained | stable | expanding |
7/9 |
2/9 |
| Q3 2019 |
2019-01-31 |
C |
lowered | mixed | expanding |
8/9 |
1/9 |
| Q2 2019 |
2018-10-26 |
C |
raised | accelerating | expanding |
7/9 |
3/9 |
| Q1 2019 |
2018-07-26 |
D |
maintained | mixed | contracting |
7/9 |
3/9 |
| Q4 2018 |
2018-05-06 |
D |
none | mixed | stable |
6/9 |
2/9 |
| Q3 2018 |
2018-01-25 |
D |
maintained | slowing | contracting |
7/9 |
2/9 |
| Q2 2018 |
2017-10-27 |
D |
none | slowing | contracting |
7/9 |
3/9 |
| Q1 2018 |
2017-07-28 |
D |
maintained | slowing | stable |
7/9 |
2/9 |
| Q4 2017 |
2017-05-07 |
D |
lowered | mixed | expanding |
7/9 |
2/9 |
| Q3 2017 |
2017-01-27 |
D |
lowered | slowing | expanding |
7/9 |
2/9 |
| Q2 2017 |
2016-10-27 |
D |
maintained | slowing | expanding |
6/9 |
5/9 |
| Q1 2017 |
2016-07-31 |
B+ |
maintained | mixed | stable |
8/9 |
1/9 |
| Q4 2016 |
2016-05-07 |
C+ |
maintained | mixed | stable |
7/9 |
1/9 |
| Q4 2015 |
2016-01-28 |
D |
maintained | slowing | stable |
7/9 |
2/9 |
Research question bank — earlier calls
During our 1,600-question research program, batches of experimental hypotheses were tested directly against some of GSIT's earlier calls. The YES answers — the rare hits — are shown; click any question to see every company that matched it. Full list: the question bank.
F
Q2 2023 earnings call
2022-10-29
1 more research questions answered NO
How to read this page
The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.
Companies with similar call quality
← GSIG All “G” companies
GSK →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our
methodology.